# 1% vs. 2 % Lignocaine for Endobronchial Ultrasound Guided Transbronchial Needle Aspiration

> **NCT02913300** · NA · COMPLETED · sponsor: **All India Institute of Medical Sciences** · enrollment: 100 (actual)

## Conditions studied

- Bronchopulmonary Diseases

## Interventions

- **DRUG:** Lignocaine 1% concentration solution
- **DRUG:** Lignocaine 2% concentration solution

## Key facts

- **NCT ID:** NCT02913300
- **Lead sponsor:** All India Institute of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2017-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02913300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02913300, "1% vs. 2 % Lignocaine for Endobronchial Ultrasound Guided Transbronchial Needle Aspiration". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02913300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*